CD4/CD8 ratio and lung cancer risk
Lancet HIV
.
2017 Mar;4(3):e103.
doi: 10.1016/S2352-3018(17)30027-9.
Authors
Gary M Clifford
1
,
Mauro Lise
2
,
Silvia Franceschi
2
,
Alexandra U Scherrer
3
Affiliations
1
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. Electronic address: cliffordg@iarc.fr.
2
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.
3
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
PMID:
28254148
DOI:
10.1016/S2352-3018(17)30027-9
No abstract available
Publication types
Letter
Comment
MeSH terms
CD4-CD8 Ratio*
CD4-Positive T-Lymphocytes
HIV Infections*
Humans
Lung
Lung Neoplasms
Grants and funding
001/WHO_/World Health Organization/International